More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-5 of 5 results

  • edgewisetx.com
  • 4
  • 3
  • 13
Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. Guided by our approach to targeting the muscle as an organ, we have combined our..
Relevance: 144.6167
  • www.akashirx.com
  • 1
  • 11
Akashi Therapeutics is a clinical stage biopharmaceutical company. Our mission is to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Akashi was founded by leading patient organizations and biotechnology industry..
Relevance: 37.306576
  • cytokinetics.com
  • 5
  • 4
  • 56
Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle..
Relevance: 31.054436
  • epirium.com
  • 1
  • 24
Epirium Bio is a biopharmaceutical company that has identified and established an IP-protected platform of orally bioavailable small molecules that constitute a new class of therapeutics with the potential to improve function in neuromuscular..
Relevance: 27.818758
  • ibioinc.com
  • 3
  • 1
  • 12
iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling..
Relevance: 16.810104